Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.410
-0.050 (-3.42%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Compugen Market Cap

Compugen has a market cap or net worth of $131.85 million as of April 1, 2025. Its market cap has decreased by -44.88% in one year.

Market Cap
131.85M
Enterprise Value
32.91M
1-Year Change
-44.88%
Ranking
Category
Stock Price
$1.41

Market Cap Chart

Since December 31, 2002, Compugen's market cap has increased from $46.50M to $131.85M, an increase of 183.56%. That is a compound annual growth rate of 4.79%.

History

DateMarket Cap% Change
Mar 31, 2025130.70M-4.60%
Dec 31, 2024137.00M-21.58%
Dec 29, 2023174.70M181.77%
Dec 30, 202262.00M-82.82%
Dec 31, 2021360.80M-64.38%
Dec 31, 20201.01B183.96%
Dec 31, 2019356.70M220.49%
Dec 31, 2018111.30M-12.91%
Dec 29, 2017127.80M-50.45%
Dec 30, 2016257.90M-19.68%
Dec 31, 2015321.10M-5.97%
Dec 31, 2014341.50M4.27%
Dec 31, 2013327.50M91.74%
Dec 31, 2012170.80M1.73%
Dec 30, 2011167.90M3.83%
Dec 31, 2010161.70M16.92%
Dec 31, 2009138.30M1,033.61%
Dec 31, 200812.20M-72.95%
Dec 31, 200745.10M-37.45%
Dec 29, 200672.10M-38.95%
Dec 30, 2005118.10M-14.61%
Dec 31, 2004138.30M4.38%
Dec 31, 2003132.50M184.95%
Dec 31, 200246.50M-
View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 741.66B
UnitedHealth Group 479.08B
Johnson & Johnson 399.65B
AbbVie 370.64B
Novo Nordisk 302.16B
Abbott Laboratories 230.06B
Merck & Co. 226.74B
AstraZeneca 225.46B
Market Cap Rankings